No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
398 |
6. Filter based on genotype QC (FinnGen only) |
398 |
Control definitions (FinnGen only)
- Control exclude
- D3_IMMUNEMECHANISM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D80-D89
- Name in latin
- Aliae deficientiae immunales
Similar endpoints
↥List of similar endpoints to
Other immunodeficiencies
based on the number of shared cases.
Similar with more cases:
- Immunodeficiencies
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2645 | 1656 | 973 |
| Only index persons | 2220 | 1431 | 789 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 45.52 | 47.81 | 41.32 |
| Only index persons | 45.60 | 47.13 | 42.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 398 | 269 | 129 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 47.84 | 46.20 | 51.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 352
- Matched controls
- 3519
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D84.18
ICD-10 Finland
Other specified defect in the complement system
+∞
111.5
101
*
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
+∞
94.1
86
*
D84.1
ICD-10 Finland
Defects in the complement system
+∞
68.0
63
*
D84.19
ICD-10 Finland
Unspecified defect in the complement system
+∞
62.4
58
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.1
45.3
224
895
T78.3
ICD-10 Finland
Angioneurotic oedema
38.9
44.5
56
17
H02AB06
ATC
prednisolone; systemic
5.1
44.5
244
1080
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
13.7
41.4
74
67
D84.8
ICD-10 Finland
Other specified immunodeficiencies
+∞
37.1
35
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
15.4
36.9
62
48
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
+∞
35.0
33
*
D84.0
ICD-10 Finland
Lymphocyte function antigen-1 [LFA-1] defect
+∞
35.0
33
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
33.9
32
*
D84.11
ICD-10 Finland
Hereditary angioedema type I
+∞
33.9
32
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
+∞
33.9
32
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
32.8
31
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
32.8
31
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.2
31.2
154
550
ZX120
NOMESCO Finland
Intravenous
6.8
31.1
85
157
R03DC03
ATC
montelukast; oral
4.8
30.8
122
350
338
Kela drug reimbursment
C1-esterase inhibitor, icatibant and conestat alfa
+∞
29.6
28
*
J45.9
ICD-10 Finland
Asthma, unspecified
4.7
28.9
115
329
C01CA24
ATC
epinephrine; parenteral
7.0
28.2
74
128
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
27.9
126
406
D84.13
ICD-10 Finland
Hereditary angioedema type III
+∞
27.5
26
*
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
6.8
27.2
73
130
J01MA14
ATC
moxifloxacin; systemic
6.8
26.3
70
123
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.1
25.9
120
391
B06AC02
ATC
icatibant; parenteral
+∞
25.3
24
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
9.8
25.1
52
61
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.5
24.7
79
175
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
10.7
24.4
48
51
J01MA12
ATC
levofloxacin; systemic
4.3
24.2
104
314
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.5
23.9
143
572
R03AC02
ATC
salbutamol; inhalant
3.2
23.8
240
1400
H02AB07
ATC
prednisone; oral
4.6
23.6
93
257
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
16.2
23.6
38
26
WW200
NOMESCO Finland
Immunization
11.0
22.8
44
45
UDH02
NOMESCO Finland
Rhinopharyngoscopy
6.7
22.6
60
104
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
22.1
21
*
XQ800
NOMESCO Finland
Prick test
5.5
21.9
69
149
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.4
21.5
88
250
UJF32
NOMESCO Finland
Coloscopy
3.5
20.9
121
461
J45.1
ICD-10 Finland
Nonallergic asthma
5.6
20.5
63
131
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.1
20.5
52
84
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
20.0
109
394
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.2
19.3
54
100
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.9
19.0
88
278
J47
ICD-10 Finland
Bronchiectasis
18.9
18.6
28
16
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.6
18.5
49
84
6BA02
NOMESCO Finland
NA
55.6
18.2
21
*
R06.0
ICD-10 Finland
Dyspnoea
3.2
17.8
113
452
B02AA02
ATC
tranexamic acid; systemic
3.5
17.7
96
343
R50.9
ICD-10 Finland
Fever, unspecified
3.5
17.4
92
320
J31.0
ICD-10 Finland
Chronic rhinitis
4.9
17.3
59
138
J01FA06
ATC
roxithromycin; oral
2.7
16.9
170
909
J01MA02
ATC
ciprofloxacin; systemic
2.7
16.9
156
793
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
16.6
105
418
Z31.5
ICD-10 Finland
Genetic counselling
5.7
16.2
48
95
R03BB04
ATC
tiotropium bromide; inhalant
5.1
16.1
53
119
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
15.9
158
831
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.9
15.7
53
122
UJF30
NOMESCO Finland
Ileoscopy through colon
4.5
15.7
59
152
J01FF01
ATC
clindamycin; systemic
2.8
15.6
125
575
TGC00
NOMESCO Finland
Bronchial lavation
13.9
15.4
26
20
H02AB09
ATC
hydrocortisone; systemic
8.0
15.4
35
48
R03BA05
ATC
fluticasone; inhalant
3.1
15.3
101
409
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
15.1
163
890
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
15.0
219
1400
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
14.8
57
150
H02AB04
ATC
methylprednisolone; systemic
3.3
14.6
83
302
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
9.8
14.5
29
32
Z2221
NOMESCO Finland
Medical doctor
2.6
14.5
136
684
R03AK07
ATC
formoterol and budesonide; inhalant
2.9
14.0
98
412
Z3231
NOMESCO Finland
Registered nurse
2.6
13.8
136
696
Z3226
NOMESCO Finland
Physiotherapist
2.8
13.8
102
442
X57
ICD-10 Finland
Unspecified privation
12.8
13.8
24
20
UJF92
NOMESCO Finland
Capsular endoscopy
11.6
13.7
25
23
D84.12
ICD-10 Finland
Hereditary angioedema type II
+∞
13.6
13
*
XF400
NOMESCO Finland
ECG with 12 standard connections
3.2
13.6
80
298
ZXD10
NOMESCO Finland
Scheduled procedure
2.4
13.6
164
934
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
13.6
103
453
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
6.1
13.3
36
64
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.3
13.2
51
134
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.4
13.2
31
45
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.7
13.1
110
513
R06AX27
ATC
desloratadine; oral
2.5
13.0
135
708
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.7
13.0
60
186
A02BC01
ATC
omeprazole; systemic
2.6
12.9
112
532
ZXE00
NOMESCO Finland
One hour or less
2.3
12.9
169
994
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
12.8
54
154
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
12.3
129
674
R03DA04
ATC
theophylline; systemic, rectal
6.4
12.3
32
54
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.3
12.1
46
119
R01AD09
ATC
mometasone; nasal
2.2
12.0
183
1145
J05AB11
ATC
valaciclovir; oral
3.3
12.0
63
215
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.1
11.9
71
265
R01AD08
ATC
fluticasone; nasal
2.4
11.9
129
684
R03AK08
ATC
formoterol and beclometasone; inhalant
6.9
11.8
29
45
A07AA02
ATC
nystatin; oral
5.3
11.8
36
74
N02AX02
ATC
tramadol; systemic, rectal
2.3
11.8
154
894
R03AC12
ATC
salmeterol; inhalant
6.1
11.8
32
57
R4110
NOMESCO Finland
Physiotherapy
2.4
11.7
117
595
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
67.3
11.7
13
*
R06AE07
ATC
cetirizine; oral
2.2
11.6
182
1148
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
11.6
51
151
ZXA10
NOMESCO Finland
Bilateral
2.8
11.6
83
350
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
11.5
87
378
J45
ICD-10 Finland
Asthma
3.5
11.5
56
181
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
15.7
11.4
18
12
J01FA10
ATC
azithromycin; systemic
2.2
11.4
232
1639
R03BA02
ATC
budesonide; inhalant
2.7
11.4
86
371
C03CA01
ATC
furosemide; systemic
2.6
11.0
92
422
R03BA08
ATC
ciclesonide; inhalant
4.0
11.0
45
125
A01AB09
ATC
miconazole; local oral
3.8
10.9
48
142
L04AB04
ATC
adalimumab; parenteral
11.1
10.9
20
19
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.7
10.9
37
86
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
18.6
10.8
16
9
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
22.3
10.8
15
7
R06AE09
ATC
levocetirizine; oral
2.7
10.7
78
332
N03AX16
ATC
pregabalin; oral
2.5
10.6
92
432
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.5
10.5
37
89
B06AC05
ATC
lanadelumab; parenteral
+∞
10.5
10
*
B06AC01
ATC
c1-inhibitor, plasma derived; parenteral
+∞
10.5
10
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
10.4
33
71
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
10.2
71
291
K50.9
ICD-10 Finland
Crohn disease, unspecified
10.5
10.1
19
19
R60.9
ICD-10 Finland
Oedema, unspecified
5.1
10.1
31
65
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
41.3
10.0
12
*
R60.0
ICD-10 Finland
Localized oedema
3.2
10.0
55
193
A02BC03
ATC
lansoprazole; oral
2.3
10.0
110
579
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
17.3
10.0
15
9
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
9.9
63
244
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.5
9.8
34
81
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
9.8
82
373
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
9.7
107
562
J46
ICD-10 Finland
Status asthmaticus
7.0
9.6
23
35
XG410
NOMESCO Finland
Flow-volume spirometry
5.2
9.5
29
60
E0000UV
ATC
NA
2.1
9.4
159
1005
C07AB07
ATC
bisoprolol; oral
2.1
9.4
142
856
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
9.4
9
*
WZC30
NOMESCO Finland
Teaching
2.8
9.4
62
247
L04AX01
ATC
azathioprine; systemic
5.2
9.3
28
57
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.2
9.3
120
675
T78.4
ICD-10 Finland
Allergy, unspecified
4.1
9.3
36
96
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.5
9.2
32
77
N02AA05
ATC
oxycodone; systemic
3.0
9.1
53
194
J45.8
ICD-10 Finland
Mixed asthma
5.5
9.1
26
50
R03BB01
ATC
ipratropium bromide; inhalant
6.1
9.1
24
42
B01AB05
ATC
enoxaparin; parenteral
2.2
9.1
103
548
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
9.0
192
1323
R51.80
ICD-10 Finland
Headache
2.5
8.9
73
330
N06AX21
ATC
duloxetine; oral
3.0
8.9
52
192
A02BC02
ATC
pantoprazole; systemic
2.0
8.8
218
1584
L50.8
ICD-10 Finland
Other urticaria
8.6
8.7
18
22
J32.4
ICD-10 Finland
Chronic pansinusitis
8.6
8.7
18
22
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
7.2
8.7
20
29
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
8.7
128
759
R01AD05
ATC
budesonide; nasal
3.4
8.6
41
130
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
16.8
8.6
13
8
R03AC03
ATC
terbutaline; inhalant
2.7
8.6
65
277
ZXA05
NOMESCO Finland
Left side
2.3
8.6
94
486
P01AB01
ATC
metronidazole; oral, rectal
2.0
8.6
149
941
A02BC05
ATC
esomeprazole; systemic
2.0
8.6
145
908
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.2
8.5
47
163
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
20.6
8.5
12
6
R06AX22
ATC
ebastine; oral
2.4
8.4
77
368
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
8.4
87
440
D80.2
ICD-10 Finland
Selective deficiency of immunoglobulin A [IgA]
+∞
8.4
8
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
8.4
8
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.8
8.3
55
218
J01DA01
ATC
[U] cefalexin; systemic
2.0
8.3
223
1653
N05CF01
ATC
zopiclone; oral
2.1
8.3
113
647
Z2446
NOMESCO Finland
Social worker
3.0
8.2
50
186
P01BA02
ATC
hydroxychloroquine; oral
3.4
8.1
39
125
R4120
NOMESCO Finland
Occupational therapy
3.7
8.1
35
103
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
8.1
46
166
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
8.1
60
256
J01DA06
ATC
[U] cefuroxime; systemic
2.6
8.0
64
282
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
5.1
7.9
24
50
N02BE01
ATC
paracetamol; systemic, rectal
2.2
7.9
290
2401
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
7.9
90
476
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.3
7.9
28
69
L50.9
ICD-10 Finland
Urticaria, unspecified
4.2
7.9
29
74
N03AX12
ATC
gabapentin; oral
2.7
7.9
58
243
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
11.2
7.9
14
13
J01FA09
ATC
clarithromycin; systemic
2.0
7.9
127
774
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.8
7.8
32
90
ZXD05
NOMESCO Finland
Urgent procedure
2.0
7.8
121
728
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
7.7
81
410
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
46.0
7.7
9
*
4AA12
NOMESCO Finland
NA
46.0
7.7
9
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
7.7
75
368
R53
ICD-10 Finland
Malaise and fatigue
2.2
7.7
81
413
A02BA02
ATC
ranitidine; systemic
2.4
7.7
70
332
J06.80
ICD-10 Finland
Continuously repeating infections of a child
25.6
7.6
10
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
5.1
7.6
23
48
A07EA06
ATC
budesonide; oral, local oral
5.5
7.5
21
40
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
13.7
7.4
12
9
XW000
NOMESCO Finland
Bone marrow biopsy
4.7
7.4
24
54
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.1
7.4
22
45
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.0
7.4
42
151
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
11.2
7.4
13
12
A06AD11
ATC
lactulose; oral
2.7
7.3
52
213
G03XA01
ATC
danazol; oral
+∞
7.3
7
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
+∞
7.3
7
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
7.3
7
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
16.2
7.3
11
7
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
7.2
35
113
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.3
7.2
36
119
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
7.2
38
131
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
30.7
7.2
9
*
V18
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident
30.7
7.2
9
*
R1250
NOMESCO Finland
Evaluation of functional capability
8.2
7.2
15
19
A09AA02
ATC
multienzymes (lipase, protease etc.)
9.1
7.1
14
16
J01DC02
ATC
cefuroxime; systemic
3.5
7.1
32
98
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
7.1
49
201
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
4.8
7.0
22
48
J01AA02
ATC
doxycycline; systemic
1.9
7.0
257
2062
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
6.9
51
216
J01DB01
ATC
cefalexin; oral
2.0
6.9
286
2392
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.3
6.9
65
312
K50.0
ICD-10 Finland
Crohn disease of small intestine
8.5
6.9
14
17
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.6
6.8
29
85
A46
ICD-10 Finland
Erysipelas
2.6
6.8
49
203
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
6.8
49
203
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
17.1
6.8
10
6
R03BA01
ATC
beclometasone; inhalant
2.5
6.7
55
247
7151E
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]
23.0
6.7
9
*
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
6.1
6.7
17
29
A01
ICPC
Pain general/multiple sites
3.2
6.7
33
109
J01FA15
ATC
telithromycin; oral
2.8
6.7
42
162
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.9
6.6
26
71
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
6.6
85
468
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
12.6
6.6
11
9
WX002
NOMESCO Finland
Sedation and analgesia
2.2
6.6
72
371
A07EC02
ATC
mesalazine; oral, rectal
3.4
6.6
30
93
N06AA09
ATC
amitriptyline; systemic
2.9
6.6
39
146
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
6.5
67
333
J02AC01
ATC
fluconazole; systemic
1.8
6.5
151
1029
J01CA04
ATC
amoxicillin; systemic
2.0
6.5
293
2493
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.7
6.5
45
184
ZXA00
NOMESCO Finland
Right side
2.0
6.5
94
543
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
7.6
6.5
14
19
D07AB08
ATC
desonide; topical
2.6
6.5
45
185
NFC40
NOMESCO Finland
Repair of hip prosthesis by bone transplant to acetabulum
71.1
6.4
7
*
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
71.1
6.4
7
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
71.1
6.4
7
*
M25.5
ICD-10 Finland
Pain in joint
1.9
6.4
111
685
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
14.7
6.4
10
7
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
6.4
30
95
C03DA01
ATC
spironolactone; oral
2.9
6.4
38
142
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
8.4
6.4
13
16
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
8.4
6.4
13
16
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
6.4
57
266
TAB00
NOMESCO Finland
Lumbar puncture
3.7
6.4
26
74
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.5
6.3
21
49
L04AA01
ATC
[U] ciclosporin; systemic
9.5
6.3
12
13
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
9.5
6.3
12
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.9
6.3
24
64
X58
ICD-10 Finland
Exposure to other specified factors
2.3
6.3
57
269
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
4.6
6.3
20
45
304
Kela drug reimbursment
Dornase alfa
+∞
6.3
6
*
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
+∞
6.3
6
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
6.3
6
*
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
+∞
6.3
6
*
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
+∞
6.3
6
*
D84.14
ICD-10 Finland
C1 esterase inhibitor deficiency (C1-INH deficiency)
+∞
6.3
6
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
6.3
6
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
+∞
6.3
6
*
L04AA06
ATC
mycophenolic acid; systemic
6.5
6.2
15
24
N06AX11
ATC
mirtazapine; oral
1.9
6.2
111
694
N05BB01
ATC
hydroxyzine; systemic
3.5
6.2
27
81
602
Kela drug reimbursment
Children's severe malnutrition
7.9
6.2
13
17
M54.3
ICD-10 Finland
Sciatica
3.6
6.2
26
76
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.1
159
1119
ZX108
NOMESCO Finland
Inhalation
12.8
6.1
10
8
S97
ICPC
Chronic ulcer skin
4.0
6.1
23
61
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
6.1
120
774
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
6.1
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
130
113
16.60
133.56
2.7
1.5
g/l
0.2
0.2
2.14
113
113
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
83
25
41.68
133.26
2.6
2.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
180
263
11.67
129.40
8.3
2.4
g/l
9.6
9.8
0.29
173
240
(3028026) IgM [Mass/volume] in Serum or Plasma
164
214
12.33
128.35
3.9
1.7
g/l
1.4
1.3
0.14
151
198
(3011412) CD3 cells [#/volume] in Blood
83
34
30.58
120.63
2.6
1.8
e9/l
1.5
1.3
0.44
73
14
(4062490)
81
33
30.56
117.87
2.4
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
76
34
27.39
106.56
2.3
1.3
g/l
0.3
0.4
0.66
62
28
(3027135) IgG subclass 1 [Mass/volume] in Serum
76
34
27.39
106.56
2.3
1.3
g/l
5.4
6.8
1.70
62
28
(3028192) IgG subclass 2 [Mass/volume] in Serum
76
34
27.39
106.56
2.3
1.3
g/l
2.8
2.7
0.03
62
27
(3005322) IgE [Units/volume] in Serum or Plasma
151
232
9.88
102.04
2.2
1.2
u/ml
321.6
225.0
0.29
145
212
(3024980) IgG subclass 4 [Mass/volume] in Serum
85
55
19.38
101.30
2.3
2.1
g/l
0.7
0.8
0.15
70
49
(3000060) B lymphocytes [#/volume] in Blood
61
20
35.84
94.73
2.4
1.6
e6/l
280.6
318.6
—
49
7
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
68
31
26.25
94.34
2.5
1.8
e9/l
0.2
0.2
0.30
61
22
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
68
32
25.42
93.15
2.5
1.7
e6/l
605.4
684.1
0.21
61
22
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
52
10
59.66
91.83
3.5
1.2
u/ml
644.2
1119.1
—
52
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
46
10
51.88
78.98
1.3
1.0
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
34
12
30.89
50.90
2.0
1.8
u/l
12.1
11.9
0.04
34
12
(42870588) Differential panel, method unspecified - Blood
255
1095
4.70
50.14
13.6
6.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
318
1655
5.58
47.52
15.6
6.1
e9/l
0.6
0.6
0.51
305
1430
(3006315) Basophils [#/volume] in Blood
318
1659
5.56
47.26
15.8
6.1
e9/l
0.0
0.0
0.09
305
1431
(3013115) Eosinophils [#/volume] in Blood
320
1710
5.45
45.21
16.1
6.7
e9/l
0.2
0.2
0.67
309
1505
(3019198) Lymphocytes [#/volume] in Blood
318
1699
5.34
44.71
15.8
6.1
e9/l
2.0
2.1
0.05
307
1509
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
65
9.25
41.16
4.2
2.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
39
31
13.84
40.62
6.0
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
35
25
15.25
38.68
2.0
2.6
%
35.8
43.3
—
11
6
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
105
275
4.83
38.27
4.6
3.2
g/l
0.2
0.2
0.59
99
262
(3007164) IgA [Mass/volume] in Serum or Plasma
195
812
3.75
37.13
3.5
1.5
g/l
1.8
2.2
3.13
162
484
(3013650) Neutrophils [#/volume] in Blood by Automated count
323
1925
4.60
34.72
18.2
9.5
e9/l
4.0
3.9
0.32
312
1665
(40758558) Short blood count panel - Blood
196
855
3.55
34.06
11.2
7.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
134
458
3.90
33.78
2.1
1.4
titre
432.7
500.0
0.24
22
98
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
31
0
+∞
32.76
1.6
0.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
103
308
4.16
31.10
2.3
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
103
308
4.16
31.10
2.7
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
124
425
3.79
30.80
3.2
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
169
714
3.38
30.18
7.5
3.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
69
7.23
28.73
2.3
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
267
1521
3.30
27.99
18.7
9.0
e9/l
0.0
0.0
0.61
233
1219
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
78
208
4.42
27.21
2.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
43
71
6.67
25.57
2.8
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
116
428
3.41
25.18
3.9
1.9
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
98
329
3.63
24.60
3.3
2.1
nmol/l
331.1
372.1
1.06
93
306
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
28
29
10.31
24.38
6.6
4.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
22
12.06
24.24
2.3
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
103
361
3.50
24.16
3.3
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
233
1312
2.87
23.37
3.8
2.5
nmol/l
77.2
75.7
0.33
221
1184
(44806118)
28
32
9.34
22.68
2.4
1.6
—
—
—
0
0
(44790048)
28
32
9.34
22.68
2.4
1.6
—
—
—
0
0
(44790047)
28
32
9.34
22.68
2.4
1.6
—
—
—
0
0
(44790049)
28
32
9.34
22.68
2.4
1.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
206
1112
2.77
22.03
6.3
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
100
374
3.24
20.86
4.1
2.7
%
19.8
22.3
1.17
91
324
(3030905) Polymorphonuclear cells [#/volume] in Blood
32
49
7.01
20.33
4.6
3.2
e9/l
4.2
4.4
0.21
32
49
(3015171) Extractable nuclear Ab [Units/volume] in Serum
51
122
4.65
20.19
1.5
1.3
u/ml
0.4
1.4
—
11
7
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
155
751
2.74
20.10
4.7
2.3
mg/l
2.9
3.1
0.46
149
653
(4010399)
70
213
3.77
20.09
1.8
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
50
6.87
19.95
2.1
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
230
1357
2.65
19.94
14.7
7.0
mmol/l
1.2
1.2
3.32
215
1241
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
47
7.07
19.87
1.9
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
114
474
2.97
19.68
7.7
4.5
mmol/l
0.8
0.8
2.19
109
449
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
32
51
6.74
19.58
4.6
3.5
%
59.1
57.1
0.30
32
51
(3000494) Fungus identified in Specimen by Culture
96
364
3.16
19.46
3.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
154
756
2.69
19.32
9.5
4.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
332
2395
3.33
18.91
17.3
7.0
u/l
79.9
81.7
0.33
324
2247
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
40
7.45
18.90
2.2
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
252
1584
2.61
18.69
10.3
6.2
umol/l
11.0
12.1
0.47
240
1494
(3023520) Reticulocytes [#/volume] in Blood
71
230
3.54
18.50
2.9
3.2
e9/l
82.5
73.9
0.93
47
169
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
51
6.51
18.40
2.2
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
164
852
2.57
18.09
5.1
3.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
50
129
4.29
17.95
2.2
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
239
1489
2.51
17.69
12.9
7.3
mmol/l
1.2
1.2
1.30
211
1277
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
28
8.66
17.68
3.0
1.1
u/ml
1.4
0.1
—
15
9
(3004588) Protein electrophoresis panel - Serum or Plasma
58
170
3.82
17.48
4.0
2.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
175
951
2.50
17.39
5.6
3.1
e6/l
70.3
127.9
0.30
148
714
(3024561) Albumin [Mass/volume] in Serum or Plasma
208
1223
2.47
17.39
10.0
4.8
g/l
35.7
36.3
0.94
199
1147
(3017181) Myelocytes/100 leukocytes in Blood
73
250
3.35
17.38
6.2
5.1
%
0.7
0.8
0.14
28
89
(3018095) Leukocytes [#/volume] in Urine
196
1128
2.45
17.10
6.7
3.7
e6/l
101.9
63.9
0.23
155
762
(3000492) Spirometry study
81
300
3.13
16.92
2.6
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
163
870
2.48
16.70
8.0
4.0
ph
7.4
7.4
0.42
30
158
(3013826) Glucose [Moles/volume] in Serum or Plasma
265
1766
2.50
16.42
10.0
4.8
mmol/l
6.3
6.5
0.93
258
1626
(3025159) Blasts/100 leukocytes in Blood
67
225
3.38
16.42
6.4
5.3
%
0.0
0.1
0.49
23
67
(3037756) Immunofixation for Serum or Plasma
28
47
6.33
16.27
1.5
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
161
864
2.45
16.19
5.3
3.0
e6/l
0.5
0.4
0.18
135
632
(3002179) Metamyelocytes/100 leukocytes in Blood
68
233
3.31
16.13
5.8
4.7
%
0.4
0.4
0.09
21
59
(3036489) Thrombin time
50
140
3.94
16.04
3.3
3.8
s
21.2
21.8
0.42
43
126
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
26
41
6.71
16.03
1.8
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
38
6.95
15.94
2.2
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
127
617
2.55
15.76
4.5
2.6
mosm/kgh2o
510.7
559.0
1.74
117
528
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
33
67
5.28
15.75
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
33
67
5.28
15.75
1.2
1.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
324
2403
2.87
15.62
11.2
3.9
mm/h
12.5
10.3
2.28
314
2231
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
27
8.16
15.43
3.0
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
135
690
2.45
14.90
4.1
3.3
ng/l
1254.8
1056.5
0.29
117
579
(3021440) Promyelocytes/100 leukocytes in Blood
66
233
3.20
14.86
6.5
5.3
%
0.0
0.1
1.94
26
77
(3000850) Epithelial cells [#/volume] in Urine
125
619
2.49
14.76
4.9
2.5
e6/l
3.6
5.9
2.76
119
540
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
25
42
6.28
14.50
1.9
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
86
358
2.79
14.42
4.4
3.5
umol/l
6.7
7.1
0.08
73
313
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
509
2.51
13.65
3.9
3.0
e6/l
1.7
2.5
0.82
68
277
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
109
524
2.49
13.59
3.8
2.8
e6/l
1.0
0.9
0.17
70
289
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
35
6.59
13.42
2.0
1.5
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
17
20
8.83
13.34
4.2
3.9
umol/l
25.5
25.8
0.03
17
20
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
31
69
4.79
13.31
1.5
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
27
54
5.29
13.08
1.1
1.2
u/ml
1.6
1.5
—
9
21
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
115
3.86
13.08
3.3
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
112
3.86
12.78
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
131
700
2.30
12.76
2.8
2.1
mg/l
0.9
1.1
0.87
116
527
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
50
164
3.34
12.62
2.2
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
34
6.46
12.59
1.9
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
26
52
5.28
12.59
3.6
2.5
—
—
—
0
0
(3012544) pH of Venous blood
78
332
2.68
12.41
11.4
5.7
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
226
1515
2.14
12.29
4.6
2.8
ug/l
99.3
97.9
0.05
221
1413
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
97
3.98
12.13
4.5
2.0
g/l
2.9
3.0
0.17
26
83
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
21
36
6.10
11.92
3.0
1.8
—
—
—
0
0
(4306422)
24
47
5.37
11.89
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
55
4.99
11.83
1.1
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
104
3.82
11.75
4.5
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
104
3.82
11.75
4.5
1.9
g/l
6.9
7.3
0.45
27
86
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
104
3.82
11.75
4.5
1.9
g/l
5.4
3.7
0.97
26
81
(3048689) Calprotectin [Mass/mass] in Stool
96
464
2.41
11.65
4.8
2.5
ug/g
112.3
94.6
0.25
85
366
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
34
91
3.99
11.55
5.5
2.3
g/l
2.4
0.7
0.76
27
83
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
36
101
3.82
11.46
2.0
2.5
g/l
1.2
1.5
1.07
27
92
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
26
57
4.81
11.35
1.2
1.2
u/ml
3.8
3.6
0.05
11
26
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
22
7.54
11.06
2.4
1.5
umol/l
27.6
16.1
0.64
16
22
(3002032) Base excess in Venous blood by calculation
73
320
2.57
10.87
11.9
5.7
mmol/l
1.9
1.7
0.12
62
245
(3000991) Gas panel - Venous blood
66
276
2.67
10.80
14.8
10.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
75
335
2.53
10.73
1.5
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
96
3.78
10.73
4.8
2.0
g/l
9.4
9.8
0.15
27
89
(3016502) Oxygen saturation in Arterial blood
62
254
2.71
10.56
8.6
8.8
%
95.8
95.2
0.36
57
243
(46235355) HIV 1 and 2 tests - Meaningful Use set
127
717
2.13
10.48
2.1
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
103
3.63
10.40
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
80
3.97
10.24
2.6
5.8
u/ml
0.3
0.4
0.41
20
43
(40767503) Oxygen content in Capillary blood by calculation
24
54
4.67
10.16
3.5
2.0
%
15.9
16.8
0.43
15
24
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
172
1097
2.00
10.11
2.3
1.9
pmol/l
94.1
97.5
0.42
101
557
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
142
846
2.05
10.09
3.6
2.1
u/l
120.2
186.9
2.80
135
805
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
96
3.66
9.97
1.9
1.5
iu/ml
0.7
0.1
0.46
15
16
(3003396) Base excess in Arterial blood by calculation
64
277
2.56
9.74
8.9
8.6
mmol/l
1.9
1.2
0.88
51
215
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
19
36
5.49
9.73
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
99
522
2.19
9.63
3.7
3.4
ng/l
476.1
364.1
0.13
53
361
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
11
10.26
9.58
1.6
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
30
84
3.78
9.57
1.7
1.2
u/ml
3.2
0.9
—
5
5
(3052851) Hemolysis interference index of Serum or Plasma
32
97
3.50
9.10
2.3
2.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
156
996
1.93
8.87
4.6
3.1
mmol/l
2.3
2.4
2.57
142
888
(3032080) INR in Blood by Coagulation assay
163
1060
1.91
8.74
12.4
7.0
inr
1.1
1.2
0.52
48
329
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
58
252
2.52
8.73
7.8
6.3
mmol/l
1.5
1.4
0.12
44
184
(3011397) Hemoglobin [Presence] in Urine by Test strip
123
730
1.99
8.62
5.1
3.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
53
4.34
8.57
1.0
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
62
281
2.43
8.52
9.6
8.5
kpa
5.2
5.1
0.15
57
268
(3027801) Oxygen [Partial pressure] in Arterial blood
62
281
2.43
8.52
9.6
8.5
kpa
11.6
12.4
0.60
57
269
(3021901) Oxygen saturation in Capillary blood
21
49
4.47
8.51
4.1
3.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
199
2.67
8.45
1.4
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
8
0
+∞
8.36
1.4
0.0
—
—
—
0
0
(3009343) pH of Capillary blood
58
259
2.45
8.23
7.9
6.1
ph
7.4
7.4
—
10
17
(3021960) Folate [Moles/volume] in Serum or Plasma
112
653
2.00
8.20
1.8
1.5
nmol/l
22.2
20.7
0.45
99
559
(3015235) Bicarbonate [Moles/volume] in Capillary blood
27
79
3.59
8.10
4.4
3.7
mmol/l
24.6
24.6
0.01
27
69
(3037467) Urinalysis macro (dipstick) panel - Urine
280
2201
1.92
7.98
7.5
4.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
17
35
5.03
7.95
2.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
27
81
3.50
7.80
1.6
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
144
930
1.86
7.68
3.8
2.4
u/l
56.7
55.9
0.10
138
858
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
14
25
5.77
7.59
3.6
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
14
25
5.77
7.59
3.6
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
14
25
5.77
7.59
3.6
1.9
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
27
85
3.33
7.26
1.8
1.2
u/ml
7.6
33.0
—
7
9
(4268621)
17
38
4.63
7.24
2.2
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
107
3.06
7.18
1.4
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
39
154
2.70
7.10
7.9
4.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
43
4.34
7.08
1.7
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
215
1595
1.76
7.01
5.7
3.4
estimate
0.0
0.0
0.00
42
311
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
103
3.07
7.01
1.7
1.2
u/ml
1.7
3.1
—
5
17
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
154
1039
1.79
6.98
5.3
3.2
ng/l
21.1
30.3
1.15
99
628
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
48
4.11
6.97
1.7
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
67
3.58
6.95
1.6
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
19
49
4.02
6.79
5.8
5.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
214
1595
1.74
6.79
7.7
4.8
estimate
0.0
0.0
0.50
42
311
(3030313) Adrenal Ab [Titer] in Serum
10
6
17.05
6.77
2.2
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
14
28
5.15
6.75
4.7
2.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
14
7.30
6.73
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
79
3.31
6.69
1.7
1.6
u/ml
76.1
102.7
—
7
12
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
154
2.62
6.58
2.3
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
561
1.91
6.55
1.8
1.6
pmol/l
44186497.8
14017187.3
0.29
86
478
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
114
715
1.83
6.51
2.7
2.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
7
14.61
6.43
2.1
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
214
1612
1.71
6.39
5.8
3.5
estimate
0.0
0.0
0.00
43
303
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
61
3.58
6.37
2.9
2.1
g/l
127.6
133.7
0.51
16
42
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
25
82
3.19
6.31
1.5
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
34
4.55
6.29
1.1
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
37
155
2.53
6.00
6.4
7.5
kpa
8.9
9.3
0.59
37
145
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
289
2.13
5.98
5.5
3.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
135
910
1.73
5.96
3.9
2.7
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
40
4.13
5.95
2.2
4.0
u/ml
36.2
127.5
—
5
11
(3016650) Hepatitis A virus Ab [Presence] in Serum
20
59
3.52
5.94
1.1
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
142
973
1.71
5.89
2.8
2.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
120
2.72
5.87
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
26
92
2.95
5.79
14.9
5.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
92
2.95
5.79
1.5
1.3
ug/g
323.1
320.0
0.02
13
49
(3026493) Urate [Moles/volume] in Serum or Plasma
116
756
1.75
5.73
5.3
2.8
umol/l
9457.6
5844.5
0.21
109
668
(4034850)
27
99
2.85
5.65
20.3
7.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
12
25
4.92
5.53
1.1
1.2
u/ml
0.4
0.4
—
7
12
(3019309) Folate [Moles/volume] in Red Blood Cells
78
456
1.88
5.48
1.8
1.6
nmol/l
1404.5
1194.1
1.01
63
342
(40768804) Tissue Pathology biopsy report
173
1273
1.64
5.35
2.5
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
9
8
11.47
5.31
2.8
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
22
5.11
5.29
1.1
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
54
3.44
5.23
1.3
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
35
4.11
5.21
1.9
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
21
70
3.11
5.18
7.5
4.7
mg/l
21.7
25.1
0.35
16
54
(3034860) Kappa light chains.free [Mass/volume] in Serum
21
70
3.11
5.18
7.5
4.7
mg/l
109.9
147.2
0.14
16
54
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
87
2.87
5.14
1.8
1.5
u/ml
233.7
221.4
0.06
15
52
(3045142) Bone marrow Pathology biopsy report
13
31
4.30
5.13
1.9
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
6
13.57
5.10
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
365
3302
2.27
5.04
38.5
12.1
mg/l
21.5
21.7
0.04
314
2501
(3002523) Influenza virus A Ag [Presence] in Specimen
22
77
2.97
5.01
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
22
77
2.97
5.01
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
191
1457
1.60
4.99
5.2
4.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
56
3.32
4.95
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
300
2559
1.70
4.91
4.9
4.0
pmol/l
14.5
14.6
0.21
284
2360
(4035726)
50
260
2.06
4.90
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
69
402
1.87
4.88
1.4
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
31
132
2.46
4.87
10.4
11.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
57
3.26
4.82
4.9
2.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
10
9.18
4.80
2.0
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
17
52
3.37
4.80
1.6
1.4
e6/l
5533.5
14413.4
0.96
11
36
(3044941) Cell count panel - Synovial fluid
13
33
4.04
4.75
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
58
3.20
4.70
1.3
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
29
122
2.49
4.68
1.5
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
16
48
3.43
4.65
2.8
1.6
mmol/l
1.5
1.5
0.07
16
48
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
92
2.71
4.65
1.7
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
45
230
2.08
4.62
3.9
2.6
ml/min/173m2
59.0
70.8
1.12
21
95
(40761535) Cells panel - Urine sediment
44
225
2.07
4.52
6.2
3.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
30
4.09
4.47
2.1
1.5
pg
33.5
33.1
0.17
12
30
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
287
2447
1.62
4.42
4.8
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
158
2.26
4.42
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
69
416
1.80
4.36
2.2
1.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
359
3262
2.03
4.34
36.5
13.4
mmol/l
139.3
139.7
2.03
354
3169
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
22
4.64
4.32
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
46
3.35
4.23
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
41
210
2.06
4.20
15.2
6.5
mmol/l
23.9
24.0
0.03
36
199
(3023103) Potassium [Moles/volume] in Serum or Plasma
359
3273
1.99
4.12
36.7
13.5
mmol/l
3.9
3.9
4.27
354
3170
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
86
2.65
4.12
1.1
1.1
u/ml
4.2
5.0
0.09
14
52
(3051611) Lipemic interference index of Serum or Plasma
12
32
3.84
4.11
2.0
2.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
122
870
1.58
4.08
4.7
3.2
mmol/l
7.4
7.7
0.42
111
750
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
7
10.15
4.02
1.3
2.6
ug/g
160.7
151.9
—
7
7
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
53
3.10
4.01
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
51
287
1.89
4.01
20.7
16.1
inr
1.1
1.3
—
8
39
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
14
6.55
4.00
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
14
6.55
4.00
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
17
59
2.97
3.95
1.4
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
24
4.25
3.91
1.9
2.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
52
298
1.86
3.87
1.7
1.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
15
6.11
3.83
1.2
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
106
743
1.58
3.78
4.8
3.2
mg/l
2246.7
241.1
1.17
71
483
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
87
583
1.63
3.73
2.1
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
12
6.78
3.69
2.0
1.5
nmol/l
132.9
142.7
—
8
12
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
14
45
3.19
3.68
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
259
1.88
3.62
1.7
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
89
605
1.61
3.59
1.5
1.3
iu/ml
23.9
32.6
0.55
32
182
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
17
5.39
3.53
2.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
17
5.39
3.53
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
6
10.13
3.51
8.0
3.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
25
113
2.29
3.49
1.7
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
47
270
1.84
3.48
1.6
1.3
iu/ml
54.9
177.7
3.90
13
111
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
502
1.64
3.44
2.7
2.7
mmol/l
2.4
2.4
0.14
65
439
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
18
5.09
3.39
2.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
7
10
7.10
3.37
1.4
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
65
2.69
3.34
1.7
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
6
7
8.68
3.27
1.8
2.3
umol/l
1.2
1.2
—
6
7
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
19
4.82
3.25
2.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
33
3.40
3.21
1.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
157
1231
1.45
3.21
6.2
3.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
15
5.42
3.20
2.1
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
15
5.42
3.20
1.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
8
15
5.42
3.20
1.3
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
38
210
1.89
3.17
2.5
2.3
e9/l
5.1
3.9
1.07
31
176
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
12
39
3.14
3.11
1.5
1.3
nmol/l
—
—
—
0
0
(3044889) 12 lead EKG panel
245
2095
1.44
3.09
4.9
3.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
29
3.51
3.06
2.5
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
16
5.08
3.06
2.1
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
87
2.37
3.06
1.1
1.1
u/ml
0.3
1.2
—
6
26
(3041096) Erythrocytes [Presence] in Urine by Automated
121
911
1.47
3.02
4.9
3.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
107
786
1.49
3.02
5.9
3.9
mg/mmol
30.3
10.3
1.04
70
489
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
321
2901
1.55
3.00
27.4
10.9
ml/min/173m2
86.4
86.8
0.09
285
2349
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
111
823
1.48
2.99
2.1
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
35
3.20
2.95
1.5
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
35
3.20
2.95
1.5
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
35
3.20
2.95
1.5
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
30
3.39
2.92
2.5
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
111
827
1.47
2.91
1.6
1.6
mmol/l
1.4
1.4
0.01
102
719
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
41
2.99
2.88
1.7
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
7
13
5.46
2.88
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
13
5.46
2.88
1.4
1.5
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
36
3.11
2.83
1.5
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
36
3.11
2.83
1.5
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
36
3.11
2.83
1.5
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
84
2.33
2.82
1.1
1.1
u/ml
0.7
0.8
0.05
14
48
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
31
3.28
2.79
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
23
3.98
2.79
1.7
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
23
3.98
2.79
1.2
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
61
403
1.61
2.76
1.4
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
14
5.07
2.74
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
14
5.07
2.74
1.7
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
119
909
1.44
2.72
1.5
1.4
u/ml
0.8
1.6
0.99
39
245
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
119
2.08
2.72
1.3
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
11
37
3.03
2.71
1.5
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
230
1.77
2.68
1.6
1.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
121
2.05
2.61
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
7
15
4.73
2.61
1.1
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
15
4.73
2.61
1.0
1.1
%
111.4
129.5
—
7
15
(3019150) Specific gravity of Urine by Refractometry
94
692
1.47
2.60
6.6
3.6
kg/l
1.0
1.0
—
10
101
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
25
3.66
2.59
1.7
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
80
571
1.50
2.57
1.5
1.3
u/ml
5.3
10.7
0.83
31
223
(3004809) Band form neutrophils/100 leukocytes in Blood
13
50
2.65
2.55
4.4
2.8
%
0.4
1.2
1.24
13
42
(42529406) Shigella sp [Presence] in Stool by Culture
24
123
2.01
2.51
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
22
110
2.06
2.46
4.6
4.7
g/l
0.4
0.3
0.45
11
56
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
97
2.12
2.41
1.2
1.2
u/ml
0.5
4.6
1.85
15
49
(3030981) Hyaline casts [#/volume] in Urine by Automated count
28
154
1.88
2.41
6.0
2.9
e6/l
0.2
0.1
0.40
28
149
(3000093) Morphology [Interpretation] in Blood Narrative
9
27
3.39
2.40
1.4
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
8
6.31
2.38
6.6
2.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
22
3.69
2.37
1.3
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
272
1.65
2.32
4.0
4.1
ug/l
10.8
48.4
0.65
33
222
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
28
3.26
2.32
2.2
2.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
8
23
3.53
2.28
3.7
3.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
13
4.67
2.28
3.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
60
414
1.53
2.26
1.7
1.8
%
1.4
1.4
0.11
54
375
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
18
3.94
2.26
1.1
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
9
29
3.15
2.24
2.7
4.8
%
111.0
103.0
—
9
29
(44813793)
9
29
3.15
2.24
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
9
5.61
2.22
1.2
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
67
2.29
2.20
1.2
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
319
2937
1.43
2.17
39.2
15.7
g/l
330.9
332.7
2.32
319
2920
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
14
4.33
2.16
3.5
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
14
4.33
2.16
3.5
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
14
4.33
2.16
3.5
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
37
2.75
2.12
1.6
1.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
10
5.05
2.07
1.2
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
10
5.05
2.07
4.2
3.4
—
—
—
0
0
(3024471) HLA-A [Type]
5
10
5.05
2.07
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
26
3.12
2.02
1.0
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
64
2.23
1.96
1.1
1.1
u/ml
1.0
3.2
—
5
28
(21494434) Karyotype in Bone marrow
8
27
3.00
1.94
1.5
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
324
3010
1.41
1.93
5.9
4.6
mu/l
1.8
2.3
0.58
312
2796
(3022313) Gas panel - Capillary blood
34
213
1.65
1.93
11.3
6.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
13
59
2.24
1.86
2.3
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
17
3.57
1.84
1.8
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
64
468
1.44
1.83
1.8
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
12
4.20
1.83
2.0
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
116
1.86
1.82
2.0
3.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
23
3.08
1.80
2.9
2.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
125
1.80
1.76
1.4
1.4
u/l
9.9
11.0
0.15
17
89
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.37
1.75
6.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.37
1.75
6.2
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
18
3.37
1.75
6.2
1.8
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
36
2.53
1.75
1.0
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
105
841
1.34
1.74
7.5
3.7
estimate
0.0
0.0
0.50
42
309
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
13
62
2.13
1.67
2.1
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
325
0.56
1.67
1.6
1.6
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
31
2.61
1.66
1.1
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
25
2.83
1.65
1.4
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
25
2.83
1.65
1.4
2.8
ug/l
13.3
23.5
—
7
25
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
242
2178
1.28
1.64
5.8
3.2
u/l
47.5
41.2
0.90
232
2073
(3020393) Adenovirus Ag [Presence] in Stool
5
14
3.60
1.62
1.2
2.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
20
3.03
1.58
2.7
3.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
57
2.14
1.56
3.1
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
40
276
1.50
1.54
7.4
3.5
—
—
—
0
0
(3013512) EKG study
95
769
1.31
1.45
4.0
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
197
1.57
1.45
1.3
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
22
2.75
1.44
1.7
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
361
3459
1.47
1.43
26.1
11.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
29
2.44
1.40
2.1
2.8
nmol/l
1.4
4.3
—
7
29
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
23
2.63
1.37
1.7
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
23
2.63
1.37
1.7
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
47
2.16
1.34
1.3
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
11
54
2.07
1.34
40.1
5.2
%
68.5
66.1
0.16
11
54
(3049717) Cytology report of Urine Cyto stain
15
83
1.84
1.33
1.9
2.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
24
2.52
1.31
2.8
1.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
6
24
2.52
1.31
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
130
1.65
1.29
1.5
1.4
miu/ml
155.8
260.0
1.11
13
69
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
7.2
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
299
2800
1.27
1.28
6.5
5.0
mmol/mol
39.5
38.8
0.54
288
2642
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
35
2.31
1.27
1.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
92
1.77
1.27
5.3
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
35
247
1.46
1.24
1.3
1.2
—
12.3
—
0
7
(3024928) Oxygen saturation in Venous blood
12
63
1.93
1.24
37.7
5.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
26
2.33
1.19
6.2
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
216
1.47
1.18
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
154
0.51
1.16
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
73
1.81
1.12
1.3
1.2
—
—
—
0
0
(4094501)
13
73
1.81
1.12
1.2
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
81
1.75
1.10
1.2
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
21
2.40
1.09
1.8
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
33
237
1.43
1.09
1.2
1.3
—
36.9
—
0
13
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
280
2961
0.82
1.05
4.1
3.6
mmol/l
1.4
1.3
2.97
258
2760
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
32
231
1.42
1.03
1.1
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
34
2.08
1.03
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
325
3104
1.26
0.99
33.3
13.5
%
39.4
40.0
1.02
265
2451
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
6
30
2.01
0.87
1.2
1.1
—
79.0
—
0
6
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
44
1.83
0.86
6.1
2.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
80
1.65
0.85
3.8
4.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
294
3073
0.83
0.83
4.5
4.0
mmol/l
1.4
1.5
1.08
277
2870
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
130
1.48
0.82
2.1
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
32
1.89
0.82
1.8
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
232
0.68
0.77
1.4
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
142
0.63
0.71
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
41
1.72
0.70
1.1
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
127
1.44
0.69
1.6
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
42
1.68
0.68
3.1
2.7
mmol/l
102.7
105.8
—
7
42
(3041354) Potassium [Moles/volume] in Venous blood
7
42
1.68
0.68
3.1
2.7
mmol/l
4.0
3.9
—
7
42
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
42
1.68
0.68
3.1
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
102
1.49
0.68
6.9
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
137
1.41
0.66
1.4
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
23
174
1.34
0.61
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
40
328
1.24
0.60
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
107
1183
0.87
0.59
2.5
2.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
329
0.78
0.57
11.7
6.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
6
36
1.68
0.57
2.5
2.4
%
68.5
55.2
—
6
24
(3003694) ABO and Rh group [Type] in Blood
104
940
1.14
0.54
1.6
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
20
152
1.33
0.53
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
20
152
1.33
0.53
2.6
1.4
mg/l
7.4
2.9
0.71
14
106
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
29
356
0.80
0.51
2.4
2.7
ug/l
0.6
0.7
0.32
20
219
(21494755) Public health laboratory ask at order entry panel
32
387
0.81
0.50
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
22
172
1.30
0.49
2.0
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
45
1.57
0.49
2.3
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
22
173
1.29
0.47
2.0
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
22
173
1.29
0.47
2.0
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
82
0.60
0.46
1.6
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
21
165
1.29
0.46
2.0
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
304
3124
0.89
0.44
5.1
4.4
mmol/l
2.8
2.8
0.05
284
2916
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
31
1.62
0.43
4.0
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
3.2
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
3.2
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
32
1.57
0.42
3.2
1.5
—
—
—
0
0
(3019225) pH of Specimen
30
250
1.22
0.41
6.4
4.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
33
1.52
0.41
3.2
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
3.2
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(4024509)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
22
179
1.24
0.38
3.0
2.3
u/l
1953.8
3159.0
—
5
64
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
292
2998
0.90
0.37
4.9
4.0
mmol/l
5.8
5.8
0.36
279
2786
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
126
0.71
0.35
2.8
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
43
1.40
0.35
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
172
1.23
0.35
2.0
2.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
43
487
0.87
0.35
3.0
4.1
%
21.9
21.8
0.01
13
212
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
73
1.38
0.35
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
221
0.81
0.34
1.4
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
46
1.31
0.33
1.2
1.5
mmol/l
5.7
7.0
—
6
31
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
302
3085
0.91
0.30
4.5
4.0
mmol/l
4.7
4.7
0.13
285
2892
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
107
0.74
0.29
2.0
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
63
1.28
0.28
1.4
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
8
66
1.22
0.27
1.9
2.5
u/ml
2.4
5.6
—
8
60
(3001019) Free T4 and TSH panel - Serum or Plasma
18
214
0.83
0.27
2.1
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
9
75
1.20
0.25
1.2
1.8
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
39
1.29
0.23
2.0
3.1
u/ml
18.2
57.7
—
5
39
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
144
1.19
0.22
2.2
2.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
11
0.00
0.21
0.0
4.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(4211845)
0
13
0.00
0.21
0.0
3.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
53
1.13
0.18
2.8
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
350
0.91
0.17
1.8
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
44
411
1.08
0.15
1.7
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
49
461
1.07
0.14
2.3
2.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
191
0.89
0.14
3.9
2.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
95
1.16
0.11
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
58
607
0.95
0.11
4.0
4.6
ug/l
1.5
2.4
0.78
50
543
(3023511) Choriogonadotropin [Units/volume] in Urine
12
106
1.14
0.10
1.4
1.3
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
47
1.06
0.09
1.2
1.1
u/l
22.0
13.5
—
5
41
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
55
1.09
0.09
1.3
1.3
ug/l
1.6
3.4
—
6
48
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
60
0.83
0.08
1.8
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
53
511
1.04
0.07
2.4
2.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
101
0.89
0.06
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
101
0.89
0.06
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
103
0.87
0.06
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
626
1.03
0.04
1.7
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
129
0.93
0.03
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
132
0.98
0.00
2.4
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
147
1.02
0.00
4.4
3.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
7
70
1.00
0.00
1.6
1.5
u/l
36.4
22.1
—
7
57
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
65.2
—
0
5
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
79
1.01
0.00
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
964.1
—
0
9
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
4.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
2.2
—
0
8
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
27.3
—
0
8
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
4.4
—
0
8
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
93
0.97
0.00
1.6
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_IMMUDEFOTHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFOTHER | 1.966 [1.61, 2.4] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.164 |
During the follow-up period (1.1.1998 — 31.12.2019), 290 out of 1479 females with D3_IMMUDEFOTHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_IMMUDEFOTHER | 2.078 [1.62, 2.67] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 187 out of 855 males with D3_IMMUDEFOTHER died.
Mortality risk
Mortality risk for people of age
years, who have D3_IMMUDEFOTHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.147% | 0.391% |
| 5 | 1.014% | 2.209% |
| 10 | 2.58% | 5.648% |
| 15 | 5.512% | 10.441% |
| 20 | 9.694% | 17.119% |
Relationships between endpoints
↥Index endpoint: D3_IMMUDEFOTHER – Other immunodeficiencies
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data